Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts This week, 27 April 2025: Treatment-resistant hypertension Influenza transmission Nanoplastics in human brains Malaria elimination Chikungunya vaccine

Gastric Cancer

Free Subscription Articles published in Gut Retrieve available abstracts of 31 articles: HTML format

Single Articles

April 2025
1. YAMADA H, Abe S, Charvat H, Ando T, et al
   Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study.
   Gut. 2025 Apr 15:gutjnl-2025-335039. doi: 10.1136/gutjnl-2025-335039.
   PubMed     Abstract available
   
   
   
2. KEMP LJS, Monster JL, Wood CS, Moers M, et al
   Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression.
   Gut. 2025 Apr 1:gutjnl-2024-334589. doi: 10.1136/gutjnl-2024-334589.
   PubMed     Abstract available
   
   
   March 2025
3. GUO X, Wang W, Cheng X, Song Q, et al
   Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer.
   Gut. 2025 Mar 20:gutjnl-2024-333657. doi: 10.1136/gutjnl-2024-333657.
   PubMed     Abstract available
   
   
   
4. YUE SSK, Tong Y, Siu HC, Ho SL, et al
   Divergent lineage trajectories and genetic landscapes in human gastric intestinal metaplasia organoids associated with early neoplastic progression.
   Gut. 2025;74:522-538.
   PubMed     Abstract available
   
   
   February 2025
5. ZENG X
   Unleashing the potential of exosome ncRNAs for early gastric cancer detection-a critical appraisal of machine learning approaches.
   Gut. 2025 Feb 23:gutjnl-2025-334909. doi: 10.1136/gutjnl-2025-334909.
   PubMed    
   
   
   
6. SHIMURA M, Matsuo J, Pang S, Jangphattananont N, et al
   IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth.
   Gut. 2025;74:364-386.
   PubMed     Abstract available
   
   
   January 2025
7. CAI ZR, Zheng YQ, Hu Y, Ma MY, et al
   Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study.
   Gut. 2025 Jan 3:gutjnl-2024-333522. doi: 10.1136/gutjnl-2024-333522.
   PubMed     Abstract available
   
   
   November 2024
8. LEE SH, Lee D, Choi J, Oh HJ, et al
   Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages.
   Gut. 2024 Nov 23:gutjnl-2024-332901. doi: 10.1136/gutjnl-2024-332901.
   PubMed     Abstract available
   
   
   
9. LI Y, Zheng Y, Huang J, Nie RC, et al
   CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases.
   Gut. 2024 Nov 12:gutjnl-2024-333617. doi: 10.1136/gutjnl-2024-333617.
   PubMed     Abstract available
   
   
   September 2024
10. DINIS-RIBEIRO M, Shah S, El-Serag H, Banks M, et al
    The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.
    Gut. 2024;73:1607-1617.
    PubMed     Abstract available
    
    
    
11. LEJA M
    Where are we with gastric cancer screening in Europe in 2024?
    Gut. 2024 Sep 4:gutjnl-2024-332705. doi: 10.1136/gutjnl-2024-332705.
    PubMed     Abstract available
    
    
    August 2024
12. BEATON DR, Sharp L, Lu L, Trudgill NJ, et al
    Diagnostic yield from symptomatic gastroscopy in the UK: British Society of Gastroenterology analysis using data from the National Endoscopy Database.
    Gut. 2024;73:1421-1430.
    PubMed     Abstract available
    
    
    July 2024
13. HUANG XB, Huang Q, Jiang MC, Zhong Q, et al
    KLHL21 suppresses gastric tumourigenesis via maintaining STAT3 signalling equilibrium in stomach homoeostasis.
    Gut. 2024 Jul 5:gutjnl-2023-331111. doi: 10.1136/gutjnl-2023-331111.
    PubMed     Abstract available
    
    
    June 2024
14. ZENG R, Gou H, Lau HCH, Yu J, et al
    Stomach microbiota in gastric cancer development and clinical implications.
    Gut. 2024 Jun 17:gutjnl-2024-332815. doi: 10.1136/gutjnl-2024-332815.
    PubMed     Abstract available
    
    
    April 2024
15. ZHANG F, Sahu V, Peng K, Wang Y, et al
    Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Gut. 2024 Apr 15:gutjnl-2023-329686. doi: 10.1136/gutjnl-2023-329686.
    PubMed     Abstract available
    
    
    February 2024
16. RUGGE M, Genta RM, Malfertheiner P, Dinis-Ribeiro M, et al
    RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates.
    Gut. 2024;73:407-441.
    PubMed     Abstract available
    
    
    January 2024
17. TAKEUCHI C, Yamashita S, Liu YY, Takeshima H, et al
    Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation.
    Gut. 2024;73:255-267.
    PubMed     Abstract available
    
    
    December 2023
18. LATORRE G, Silva F, Montero I, Bustamante M, et al
    Comparison of OLGA and OLGIM as predictors of gastric cancer in a Latin American population: the ECHOS Study.
    Gut. 2023 Dec 26:gutjnl-2023-331059. doi: 10.1136/gutjnl-2023-331059.
    PubMed    
    
    
    
19. MORAIS R, Libanio D, Dinis Ribeiro M, Ferreira A, et al
    Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score.
    Gut. 2023;73:105-117.
    PubMed     Abstract available
    
    
    
20. TAN P, Chu Y
    Single-cell profiling of gastric cardia adenocarcinoma reveals drivers of cancer stemness and therapeutic targets.
    Gut. 2023;73:1-2.
    PubMed    
    
    
    
21. WANG Z, Wang Q, Chen C, Zhao X, et al
    NNMT enriches for AQP5(+) cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma.
    Gut. 2023;73:63-77.
    PubMed     Abstract available
    
    
    November 2023
22. LAHNER E, Dilaghi E, Dottori L, Annibale B, et al
    Not all that is corpus restricted is necessarily autoimmune.
    Gut. 2023;72:2384-2385.
    PubMed    
    
    
    August 2023
23. LEJA M
    Potential of personalised approaches in gastric cancer prevention.
    Gut. 2023 Aug 27:gutjnl-2023-330215. doi: 10.1136/gutjnl-2023-330215.
    PubMed    
    
    
    July 2023
24. XU Z, Huang Y, Hu C, Du L, et al
    Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study.
    Gut. 2023 Jul 17:gutjnl-2023-330045. doi: 10.1136/gutjnl-2023-330045.
    PubMed     Abstract available
    
    
    
25. CAO LL, Lu H, Soutto M, Bhat N, et al
    Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-gamma signalling.
    Gut. 2023 Jul 4:gutjnl-2022-329134. doi: 10.1136/gutjnl-2022-329134.
    PubMed     Abstract available
    
    
    May 2023
26. LEI WY, Lee JY, Chuang SL, Bair MJ, et al
    Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method.
    Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871.
    PubMed     Abstract available
    
    
    
27. ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al
    Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis.
    Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052.
    PubMed    
    
    
    April 2023
28. RALSER A, Dietl A, Jarosch S, Engelsberger V, et al
    Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal immunity and inducing a mucus-degrading microbiota signature.
    Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075.
    PubMed     Abstract available
    
    
    
29. FAN Y, Li Y, Yao X, Jin J, et al
    Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.
    Gut. 2023;72:624-637.
    PubMed     Abstract available
    
    
    March 2023
30. XU C, Huang KK, Law JH, Chua JS, et al
    Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.
    Gut. 2023 Mar 14:gutjnl-2022-328332. doi: 10.1136/gutjnl-2022-328332.
    PubMed     Abstract available
    
    
    February 2023
31. RUGGE M, Genta RM, Malfertheiner P, Graham DY, et al
    Gastric cancer risk in autoimmune gastritis: evidence versus opinion.
    Gut. 2023 Feb 27:gutjnl-2023-329618. doi: 10.1136/gutjnl-2023-329618.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.